To date, no case of monkeypox has been detected in Guadeloupe and the northern islands. However, these territories have been placed in a vigilance phase since Friday May 20 under the aegis of the Regional Health Agency, like the rest of the national territory.
This device currently concerns the medical community, in other words, the CHU, the Institut Pasteur and the regional union of health professionals.
It essentially consists of informing city practitioners about the disease itself and about what to do in the event of suspicion.
If such a case were to occur, the protocol in force provides for strict isolation of the suspect person, pending the results of the analyzes which would then be carried out in a laboratory in France. The Pasteur Institute of Guadeloupe is not yet equipped to carry out these new tests.
Two suspected cases have been detected in Guyana. The information was made public yesterday afternoon by the ARS. For the time being, no braking measures have been announced for air service to and from Guyana.
And all the more so since the first suspected case is now cured. The second person who lives under the same roof has been placed in solitary confinement. According to the ARS, his condition is stable and does not present any concern.
Monkeypox or monkeypox is a rare disease caused by infection with the monkeypox virus.
Most cases have occurred in Africa and the risk of catching monkeypox remains low.
- high temperature
- muscle aches
- Back ache
- swollen glands
A rash then usually begins one to five days after the first symptoms appear. The spots often start on the face before spreading to other parts of the body.
Over the course of the disease, the rash then changes from raised red bumps to fluid-filled spots, with the spots eventually forming scabs which later fall off.